Global Pulmonary Arterial Hypertension (PAH) Drugs Market 2017-2021

SKU ID : TNV- 10362181

Publishing Date : 12-Apr-2017

No. of pages : 70

PRICE
2500
4000

  • About Pulmonary Arterial Hypertension (PAH) Drugs
    PAH in the arteries, which carry blood from the heart to the lungs, occurs when blood vessels become narrow, making blood flow difficult.

    Technavio’s analysts forecast the global pulmonary arterial hypertension drugs market to grow at a CAGR of 3.2% during the period 2017-2021.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global pulmonary arterial hypertension drugs market for 2017-2021. To calculate the market size, the report considers the MoA and the RoA.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Pulmonary Arterial Hypertension Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Actelion Pharmaceuticals
    • DAIICHI SANKYO
    • GlaxoSmithKline
    • Novartis
    • United Therapeutics
    Other prominent vendors
    • AADi
    • Actelion Pharmaceuticals
    • Aires Pharmaceuticals
    • Arena Pharmaceuticals
    • Asklepion Pharmaceuticals
    • AstraZeneca
    • Bayer Healthcare
    • Berlin Cures
    • BIAL
    • DEKA Research & Development
    • Dong- A ST
    • Eiger BioPharmaceuticals
    • Gilead Sciences
    • Lung Biotechnology
    • Merck
    • Northern Therapeutics
    • Pfizer
    • PhaseBio Pharmaceuticals
    • Radikal Therapeutics
    • Reata Pharmaceuticals
    • SteadyMed Therapeutics
    • Velo Bio

    Market driver
    • New disease-modifying therapies
    • For a full, detailed list, view our report

    Market challenge
    • Patent expiries of major drugs

    • For a full, detailed list, view our report

    Market trend
    • Increased focus on combination therapies
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2021 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.





    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports